Health TrialsbyHealthPanel

Renal Anemia in Non-dialysis Chronic Kidney Disease

2

Review clinical trials related to Renal Anemia in Non-dialysis Chronic Kidney Disease. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Use of Pegmolesatide in Renal Anemia: Efficacy and Safety of Switching to Pegmolesatide in Non-dialysis CKD Patients Treated With rhuEPO or HIF-PHI

This was a multicenter, randomized, open label, non inferiority clinical study. It consisted of a 24-week treatment period (0-24 weeks) and a 24-week extension period (25-48 weeks). About 160 patients which had received Recombinant human erythropoietin (rHuEPO) or Hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) treatment were randomized in a 1:1 ratio to receive Pegmolesatide with different administration regimens.

Participants needed: 160
Trial details
Phase: Phase 4Age: 18-80Biological sex: AllType: InterventionalSponsor: The First Affiliated Hospital of Dalian Medical UniversityUpdated: Sep 2, 2026Locations: 1
Eligibility criteria

Aged ≥18 years and ≤80 years, regardless of gender; [+4]

Known to have hematological disorders or other diseases that cause anemia other... [+9]

Read more
Status: Not yet recruiting

Enarodustat Tablets at Different Initial Doses for Anemia in Non-dialysis CKD Patients

To evaluate the rationality of different initial doses of enarodustat for the treatment of anemia in ND-CKD patients

Participants needed: 120
Trial details
Phase: Phase 4Age: 18-75Biological sex: AllType: InterventionalSponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd.Updated: Jul 23, 2025Locations: 1
Eligibility criteria

Male or female patients aged 18-75 years (inclusive); [+5]

Patients with SF ≤100 μg/L and TSAT ≤20% at screening; [+22]

Read more